Table 1.
Characteristics of men who participated versus those who dropped out of The Olmsted County Study of Urinary Symptoms and Health Status among Men, Rochester, Minnesota (1989–2003)
Baseline Questionnaire† | |||||
Participated | Dropped out‡ | ||||
No. | % | No. | % | Chi-sq p | |
AGE (years) | |||||
40–49 | 734 | 46.7 | 336 | 49.3 | 0.01 |
50–59 | 458 | 29.2 | 138 | 20.2 | |
60–69 | 293 | 18.7 | 105 | 15.4 | |
70+ | 85 | 5.4 | 103 | 15.1 | |
AUASI* | |||||
≤ 7 | 1105 | 70.4 | 452 | 66.3 | 0.05 |
> 7 | 465 | 29.6 | 230 | 33.7 | |
QMAX (mL/s)* | |||||
≥ 12 | 1297 | 82.8 | 532 | 78.2 | 0.01 |
< 12 | 269 | 17.2 | 148 | 21.8 | |
PSA (ng/mL)* | |||||
≤ 1.4 | 329 | 75.3 | 107 | 70.9 | 0.28 |
> 1.4 | 108 | 24.7 | 44 | 29.1 | |
VOL (cm3)* | |||||
≤ 30 | 300 | 68.8 | 94 | 62.7 | 0.17 |
> 30 | 136 | 31.2 | 56 | 37.3 |
* AUASI, American Urological Association Symptom Index; QMAX, peak urinary flow rate; PSA, Prostate-Specific Antigen; VOL, prostate volume.
† Age was calculated based on the age at baseline questionnaire completion.
‡ No questionnaire completed in seventh biennial contact year.
§ Men who died between contacts were excluded, n = 195.
¶ Of the 195 excluded men, 46 were men in the clinic subset.
# PSA and VOL measurements are from the randomly selected in-clinic subset, n = 588.